Institutional shares held 168 Million
920K calls
1.06M puts
Total value of holdings $6.19B
$33.8M calls
$38.9M puts
Market Cap $3.22B
87,697,600 Shares Out.
Institutional ownership 192.12%
# of Institutions 298


Latest Institutional Activity in RVMD

Top Purchases

Q1 2025
Harbor Capital Advisors, Inc. Shares Held: 35.4K ($1.3M)
Q1 2025
Sg Americas Securities, LLC Shares Held: 18.1K ($665K)
Q1 2025
Rhumbline Advisers Shares Held: 257K ($9.45M)
Q1 2025
Parallel Advisors, LLC Shares Held: 511 ($18.8K)
Q1 2025
Rakuten Securities, Inc. Shares Held: 200 ($7.35K)

Top Sells

Q1 2025
Gamma Investing LLC Shares Held: 602 ($22.1K)
Q1 2025
Farther Finance Advisors, LLC Shares Held: 430 ($15.8K)
Q1 2025
Avanza Fonder Ab Shares Held: 2.88K ($106K)
Q1 2025
Handelsbanken Fonder Ab Shares Held: 43.8K ($1.61M)
Q1 2025
Exchange Traded Concepts, LLC Shares Held: 3.26K ($120K)

About RVMD

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.


Insider Transactions at RVMD

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.97M Shares
From 21 Insiders
Grant, award, or other acquisition 265K shares
Open market or private purchase 1.3M shares
Exercise of conversion of derivative security 399K shares
Sell / Disposition
495K Shares
From 11 Insiders
Open market or private sale 469K shares
Bona fide gift 2.72K shares
Sale (or disposition) back to the issuer 1.81K shares
Grant, award, or other acquisition 20.8K shares

Track Institutional and Insider Activities on RVMD

Follow Revolution Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD